Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

By Razis E.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 447-456

Springer Publishing Company

Access to resources Recommend Favorite

PIK3CA mutations in breast cancer are associated with poor outcome

By Li Shao   Rong Minna   Grieu Fabienne   Iacopetta Barry  

Breast Cancer Research and Treatment, Vol. 96, Iss. 1, 2006-03 ,pp. : 91-95

Springer Publishing Company

Access to resources Recommend Favorite

Mutations of the PIK3CA gene in ovarian and breast cancer

By Bellacosa Alfonso  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 223-225

Informa Healthcare

Access to resources Recommend Favorite

The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma

By Konopka Bożena   Janiec-Jankowska Aneta   Paszko Zygmunt   Goluda Marian  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 2, 2004-02 ,pp. : 114-121

Springer Publishing Company

Access to resources Recommend Favorite

PIK3CA Mutations and BRCA1 Expression in Breast Cancer: Potential Biomarkers for Chemoresistance

By Santarpia Mariacarmela   Altavilla Giuseppe   Margeli Mireia   Cirauqui Beatriz   Mesiti Mario   Cavallari Vittorio   Ramirez Jose Luis   Sanchez-Ronco Maria   Santarpia Libero   Taron Miquel   Rosell Rafael  

Cancer Investigation, Vol. 26, Iss. 10, 2008-12 ,pp. : 1044-1051

Informa Healthcare

Access to resources Recommend Favorite